AP-12009
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AP-12009, covering 2013-12-03 to 2014-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma [Phase 3]